Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT04269369
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 years or older
* WHO (world health organization) classification 0,1 or 2
* A suspected start with 5-FU or capecitabine in mono or combination therapy
* The knowledge of the result of the geno and phenotyping before the start of the treatment
Exclusion Criteria:
* Not meeting inclusion criteria
* Homozygote genotype or uracil 100 ng/ml or greater
* The lacking of the result of the geno and / or phenotyping before the start of treatment
* Patients who received 5-FU or capecitabine in the past
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04269369
Study Brief:
Protocol Section:
NCT04269369